Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | HTR2A | P28223 | 2/20 | 0.41 |
| ▸ | DRD3 | P35462 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.36 |
| ▸ | PPARG | P37231 | 3/20 | 0.36 |
| ▸ | PPARD | Q03181 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25845717 | 0.85 | FFAR1 (0.43) | FFAR1PPARGPPARD | |
| SCHEMBL25846397 | 0.85 | PPARD (0.52) | FFAR1PPARGPPARD | |
| SCHEMBL25845849 | 0.80 | CD274 (0.36) | CD274DRD2HTR2ADRD3KMT2A | |
| SCHEMBL25845680 | 0.78 | FFAR1 (0.42) | FFAR1PPARGPPARD | |
| SCHEMBL25845682 | 0.78 | FFAR1 (0.42) | FFAR1PPARGPPARD | |
| SCHEMBL25846371 | 0.77 | FFAR1 (0.51) | FFAR1PPARGPPARD | |
| SCHEMBL25844258 | 0.77 | FFAR1 (0.51) | FFAR1PPARGPPARD | |
| SCHEMBL25845730 | 0.77 | FFAR1 (0.41) | FFAR1PPARGPPARD | |
| SCHEMBL25846492 | 0.77 | CD274 (0.38) | CD274KMT2ARAB9ANPC1FFAR1 | |
| SCHEMBL25845756 | 0.76 | FFAR1 (0.43) | FFAR1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4212528-A1 | BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUND AND MEDICAL APPLICATION THEREOF | AB Pharma Ltd. (CN) | 2023-07-19 | — | — | EP | disclosed |